Navigation Links
Disease Control App for Doctors Wins Health 2.0 Data Challenge, Analyze This!
Date:3/22/2011

SAN FRANCISCO, March 22, 2011 /PRNewswire/ -- Practice Fusion has named Epicenter the winner of Analyze This! part of Health 2.0's Spring Developer Challenge. Using Practice Fusion's sample of 15,000 de-identified health records, available free through Microsoft's Windows Azure Marketplace, Epicenter developer and self-confessed "data nerd," John Schrom, said his application could help identify and better control the spread of disease across America.

(Logo: http://photos.prnewswire.com/prnh/20091118/PFLOGO)

"Epicenter allows doctors to benchmark local patient data against a uniform dataset to identify anomalies in real-time," said Schrom. "It would also allow doctors to quickly identify local disease outbreaks, the groups they're occurring in, and then share those high-risk patient profiles with the wider medical community to drive proactive treatment initiatives, more targeted screening and faster warnings." A video demonstration of Schrom's Epicenter application can be viewed here.

As part of the Health 2.0 and US Department of Health and Human Services' (HHS) Developer Challenge, Analyze This! entrants were asked to use Practice Fusion's dataset to answer pressing public health questions around obesity trends, drug efficacy, disease outbreaks and treatment outcomes.

Schrom, a 26 year old epidemiologist with Hennepin County Medical Center in Minneapolis, believes increased access to de-identified patient data is critical to the development of potentially lifesaving healthcare informatics tools, like Epicenter.

"De-identified patient data is the best way to find health trends that would be missed otherwise – a broad view of what's happening on a national scale provides small practices ways to find out how their patient data matches up against national health quality measures and allows doctors to identify and mitigate risk better and faster," said Schrom.

The Windows Azure Marketplace dataset provided by Practice Fusion's Research Division for the Analyze This! contest included data on vitals, diagnoses, medications, prescriptions, immunizations and allergies in a de-identified, HIPAA-compliant format. Matthew Douglass, Practice Fusion's Vice President of Product Development, said applications like Epicenter illustrate the scope of possibility for data-driven health applications in the medical field.

"Researchers, developers and universities all need access to de-identified medical data to help inform studies, identify health trends and ultimately improve the standard of care for patients everywhere," said Douglass. "Analyze This! winner, Epicenter, shows us that a health dataset, such as Practice Fusion's, has a profound real-world use; enabling doctors in everyday clinics to analyze and better understand their own patient data for actionable insights."

Schrom receives $5,000 for his winning entry, as well as a ticket to Health 2.0 San Diego, where he'll deliver a live demo of the application on stage. Other finalists in the Health 2.0 Analyze This! competition included:

  • ScriptDrift: a web application used to analyze and interpret prescription data, including the relationships between medications, medical conditions, doses, doctors, patients, and how these factors intersect.
  • Red Corner: an interactive, color coded, 3D visualization of patient population health, including blood pressure, height, temperature, BMI, and other vital signs.
  • QuaMe (Quantified.Me): an iPad application that visualizes a user's personal health data (e.g., age, gender, BMI, chronic conditions) against the entire population to deliver peer group comparisons.

Practice Fusion's de-identified health dataset is a powerful resource available to the health sector for developing the latest treatments, medicines and care processes. More than 70,000 doctors and nine million patients make up Practice Fusion's health community, representing one of the largest and most comprehensive views of America's health in aggregate. Supported by Government health initiatives including Health.data.gov, Practice Fusion and Microsoft, through the Windows Azure Marketplace, are focused on delivering increased open access to broad-scale health data.

About Practice Fusion's Research Division

Practice Fusion's Research Division provides information from one of the largest, longitudinal clinical databases in the US for the purposes of clinical research and public health analysis. With a focus on real-time insight into adverse drug reactions, disease outbreaks and other national health issues, Practice Fusion's Research Division powers studies that are providing new insight into healthcare and how it is delivered.

Press Contact
Lilly Hanscom
San Francisco: 415.992.5439
Lhanscom@practicefusion.com

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Matt Douglass

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=93797


'/>"/>
SOURCE Practice Fusion
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
2. CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases
3. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
4. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
5. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
6. Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease
7. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
8. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
9. Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease
10. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
11. Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
(Date:2/23/2017)... ... 2017 , ... BellBrook Labs is formalizing a significant expansion ... biochemical analyses critical for Lead Discovery. The company’s Lead Discovery Services will ... inhibitor potency and selectivity, mechanism of action, and inhibitor residence times on drug ...
(Date:2/23/2017)... Minn. , Feb. 23, 2017  Imanis ... new product line of oncolytic vaccinia viruses for ... Corporation as part of Genelux,s proprietary, vaccinia virus-based ... are excited to enter into a partnership with ... selected oncolytic vaccinia viruses for use in research," ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, ... partnership with Compass Research . GGI's mission is to advance global health and ... child in need in honor of each clinical trial volunteer. The vision of GGI ...
Breaking Biology Technology:
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
Breaking Biology News(10 mins):